2008 Annual Meeting | Dementia Evaluation in the Office

Date Monday 04/14/08

Time 06:45 AM - 08:30 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Breakfast Seminar

Director(s) Zoe Arvanitakis, MD, MS, FAAN

Topic(s) Practice Management

Learning Objectives Participants should be able to recognize the key clinical features of and implement a management plan for the most common degenerative dementias, including Alzheimer's disease, Lewy body disease, and frontotemporal dementia, as well as the most common nondegenerative dementia, vascular dementia; distinguish among older persons with normal cognitive function, those with mild cognitive impairment, and those with Alzheimer's disease; and acquire an approach to the evaluation of atypical forms of dementia.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Advanced

Recommended Audience Practitioner, Fellow, Resident, Nurse

Event Timeline
06:45 AM - 07:15 AM		Alzheimer's Disease and Mild Cognitive Impairment Ronald C. Petersen, MD, PhD, FAAN
06:45 AM - 08:30 AM		Breakfast
07:15 AM - 07:45 AM		Vascular Dementia and Lewy Body Disease Julie A. Schneider, MD, MS
07:45 AM - 08:15 AM		Frontotemporal Dementia and Evaluation of Atypical Dementias Zoe Arvanitakis, MD, MS, FAAN
08:15 AM - 08:30 AM		Questions and Answers

Faculty Disclosures
Ronald C. Petersen, MD, PhD, FAAN	Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
Julie A. Schneider, MD, MS	Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Schneider has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for alnylam. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for apellis. Dr. Schneider has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for National Hockey League. The institution of Dr. Schneider has received research support from NIH. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a scientific advisor with Fondation Alzheimer, France.
Zoe Arvanitakis, MD, MS, FAAN	Dr. Arvanitakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc.. Dr. Arvanitakis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Dementia. Dr. Arvanitakis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for a private legal firm representing a governement entity. The institution of Dr. Arvanitakis has received research support from National Institutes of Health (NIH). The institution of Dr. Arvanitakis has received research support from Amylyx. The institution of Dr. Arvanitakis has received research support from Lilly. Dr. Arvanitakis has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with The National Institutes of Health and California State (California Institute for Regenerative Medicine or CIRM). Dr. Arvanitakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant and Educator with Summus Global, Inc.

��ɫ��

��ɫ��